Medicare Enrolled

Dr. Robert Chilton, DO

Cardiovascular Disease · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
903 W MARTIN ST, San Antonio, TX 78207
2103583555
In practice since 2006 (19 years)
NPI: 1538276514 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chilton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chilton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chilton

Dr. Robert Chilton is a cardiovascular disease in San Antonio, TX, with 19 years in practice. Based on federal Medicare data, Dr. Chilton performed 13 Medicare services across 13 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chilton received a total of $1,422,641 from 48 pharmaceutical and/or device companies across 992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chilton is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 13 Medicare services$ $1,422,641 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13
Medicare services
13
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes13$10$36
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,422,641
Total received (2018-2024)
Avg $203,234/year across 7 years
Top 0% in TX for cardiovascular disease
48
Companies
992
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,156,240 (81.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$174,056 (12.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$92,344 (6.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$145,678
2023
$169,208
2022
$209,676
2021
$248,693
2020
$148,203
2019
$227,296
2018
$273,886

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$393,009
Lilly USA, LLC
$254,256
Boehringer Ingelheim Pharmaceuticals, Inc.
$202,762
Merck Sharp & Dohme LLC
$137,021
AstraZeneca Pharmaceuticals LP
$59,828
Merck Sharp & Dohme Corporation
$45,997
Boehringer Ingelheim South Africa (Pty) Ltd
$40,832
Boehringer Ingelheim International GmbH
$37,566
Takeda Pharmaceuticals International, Inc.
$34,965
SANOFI-AVENTIS U.S. LLC
$34,782
Boehringer Ingelheim MENA (Scientific Office) FZ-LLC
$28,785
Boehringer Ingelheim (Phil.) Inc.
$27,950
Boehringer Ingelheim Taiwan Ltd.
$22,554
Boehringer Ingelheim, Unipessoal, Lda.
$18,981
Eli Lilly and Company
$12,620
Regeneron Pharmaceuticals, Inc.
$12,416
Amgen Inc.
$10,134
AstraZeneca UK Limited
$9,541
Amarin Pharma Inc.
$8,319
Dr.Reddy's Laboratories,Inc.
$7,800
Boehringer Ingelheim Singapore Pte. Ltd.
$6,700
Boehringer Ingelheim Mexico SA de CV
$3,982
Medtronic, Inc.
$3,964
Abbott Laboratories
$3,260
ABIOMED
$900
Medtronic Vascular, Inc.
$551
BIOTRONIK INC.
$476
AngioDynamics, Inc.
$440
HeartFlow, Inc.
$278
Boston Scientific Corporation
$276
Novartis Pharmaceuticals Corporation
$252
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$160
LivaNova USA, Inc.
$147
Osprey Medical Inc
$143
Shockwave Medical, Inc
$125
Novo Nordisk AS
$125
Janssen Scientific Affairs, LLC
$123
BOSTON SCIENTIFIC CORPORATION
$119
Bayer HealthCare Pharmaceuticals Inc.
$110
Inari Medical, Inc.
$100
Corcept Therapeutics
$85
EKOS Corporation
$65
Janssen Pharmaceuticals, Inc
$38
Lexicon Pharmaceuticals, Inc.
$34
Impulse Dynamics (USA) Inc.
$23
Lantheus Medical Imaging, Inc.
$21
Philips Electronics North America Corporation
$17
ZOLL Circulation Inc
$12
Top 3 companies account for 59.7% of total payments
Associated products mentioned in payments ›
ACIST RXI SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AZURE XT DR MRI SURESCAN · Asahi Fielder coronary guide wire · Astron; Pulsar; AstronPulsar · BRILINTA · CoreValve Evolut · DEFINITY · DRAGONFLY OPSTAR · DyeVert · EKOSONIC · ENSITE PRECISION · ENTRESTO · EVENITY · Edarbi · FARXIGA · FFRct · FLOWTRIEVER CATHETER · GALLANT · GENERAL THERAPIES · GLYXAMBI · General - Atherectomy · HawkOne · IGT Devices Und · INVOKANA · Impella · JARDIANCE · Kerendia · Korlym · LEQVIO · Legacy · LifeVest · MICRA · Micra · Mini Trek catheters · NC TREK coronary catheters · NO PRODUCT DISCUSSED · ONYX FRONTIER · OPTIMIZER · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · Passeo-18 · Pulsar-18 T3 · RESOLUTE ONYX · RYBELSUS · Repatha · Resolute · Rybelsus · S · SOLIQUA · SQ-RX PULSE GENERATOR · TELESCOPE · TRADJENTA · TRULICITY · Tandem Life Kit · TandemLife · Telescope · Temperature Management System · Ultreon · VERQUVO · Vascepa · Vascular Lithotripsy · Victoza · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in TX.

Equivalent to $10,943,393 per 100 Medicare services performed
Looking for a cardiovascular disease in San Antonio?
Compare cardiovascular diseases in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
150
Per 100K population
7.4
County median income
$70,571
Nearest hospital
CHILDREN'S HOSPITAL OF SAN ANTONIO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chilton is a mixed practice specialist, and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chilton experienced with use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes?
Based on Medicare claims data, Dr. Chilton performed 13 use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chilton receive payments from pharmaceutical companies?
Yes. Dr. Chilton received a total of $1,422,641 from 48 companies across 992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chilton's costs compare to other cardiovascular diseases in San Antonio?
Dr. Chilton's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chilton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →